SCM
MYOK

Silvant Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Silvant Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,885
Closed -$257K – 340
2020
Q3 		$257K Buy
+1,885
New +$200K 0.05% 157

Silvant Capital Management's MYOK Position: Q4 2020 in Review

Silvant Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 1,885 shares — an estimated $257K sold.

Silvant Capital Management first reported a position in MYOK in Q3 2020 and held it in 1 quarter. The position peaked at $257K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Silvant Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Silvant Capital Management sold 1,885 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $257K.
  • Silvant Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Silvant Capital Management's MyoKardia, Inc. Common Stock position peaked at $257K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Silvant Capital Management's 13F filing for Q4 2020, filed 5 Feb 2021.